Mode
Text Size
Log in / Sign up

Antidepressants combined with psychotherapy do not significantly improve depression severity in major depressive disorderAdding antidepressants to psychotherapy may not improve depression severity

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that adding antidepressants to psychotherapy does not show a significant benefit for major depressive disorder.

This meta-analysis synthesized evidence regarding the efficacy of combining antidepressants with psychotherapy for the treatment of major depressive disorder. The analysis focused on comparing antidepressant plus psychotherapy against a comparator of psychotherapy plus a placebo to determine impacts on depression severity.

The primary findings indicated that adding antidepressants to psychotherapy did not result in significant improvements in change-from-baseline scores (SMD = 0.31; 95% CI -0.07 to 0.70; p-value = 0.1). Furthermore, endpoint depression scores showed no significant difference between the two treatment groups.

The authors noted several limitations, including a small number of trials, significant intervention heterogeneity, and the inclusion of selected populations. These factors, combined with the very low GRADE certainty rating, suggest that the evidence is insufficient to confirm a clinical benefit for this combination. Current evidence does not indicate a clear benefit of adding antidepressants to psychotherapy for patients with major depressive disorder.

How this fits prior evidence

This meta-analysis addresses the clinical utility of adjunctive antidepressant therapy. While prior evidence suggests that lumateperone 42 mg plus ADT improves MADRS scores in MDD with anxious distress, this meta-analysis finds no significant benefit in adding antidepressants to psychotherapy for MDD generally. The results do not confirm the potential for improved outcomes in specific subsets, and the very low certainty of evidence suggests caution when interpreting the lack of benefit for the combined approach.

Living with major depressive disorder is incredibly hard, and many people look for the most effective way to find relief. One common approach is combining talk therapy with antidepressant medications. However, recent evidence suggests that adding these medications to a therapy plan might not actually change the severity of the condition compared to therapy alone.

Researchers looked at several trials to see if adding antidepressants helped patients more than just taking a placebo alongside their therapy. The results were not significant, meaning the data did not show a clear benefit from the extra medication. Because the evidence is currently very low in certainty, it is hard to say for sure how much of a difference the drugs make in this specific combination.

It is important to note that these findings come from a small number of trials with some inconsistencies in how the studies were set up. Because the evidence is still limited and the data is not definitive, patients should talk to their doctors to decide which treatment plan is best for their specific needs.

What this means for you:
Adding antidepressants to psychotherapy may not improve depression scores for those with major depressive disorder.

Common questions

Does adding antidepressants to talk therapy help with depression?

Current evidence does not show a clear benefit from adding antidepressants to psychotherapy for people with major depressive disorder. The results were not significant, meaning the data did not show that the combination worked better than therapy plus a placebo.

Why is the evidence for this treatment uncertain?

The certainty of these findings is very low. This is because the analysis included only a few trials and faced issues like inconsistent methods and different types of patients across the studies.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
BACKGROUND: Major depressive disorder (MDD) impairs daily functioning and is often treated with psychotherapy, antidepressants (AD), or both. While combined therapy is recommended, its efficacy remains unclear. This systematic review and meta-analysis aimed to evaluate the efficacy of adding an AD to psychotherapy, compared with psychotherapy plus a placebo. METHODS: A systematic search was conducted across PubMed, Embase, and Cochrane Central for randomized controlled trials. Studies were included if they compared AD in addition to psychotherapy versus psychotherapy plus a placebo, with depression severity assessed using standardized scales. Meta-analyses were performed on depression severity outcomes, using change-from-baseline scores and endpoint scores. OUTCOMES: Eleven trials were included, involving various AD and psychotherapies. The pooled effect size for change-from-baseline scores across trials showed a nonsignificant result SMD = 0.31; CI 95% (-0.07; 0.70) (p-value = 0.1). Meta-analyses based on endpoint depression scores were non-significant, and the observed effect sizes may fall below the threshold for clinical significance. The quality of evidence was rated as very low according to the GRADE assessment. CONCLUSION: Current evidence does not indicate the benefit of adding antidepressants to psychotherapy for MDD. Evidence quality is very low, with few trials, methodological limitations, intervention heterogeneity, and selected populations limiting interpretability and generalizability. Larger, high-quality RCTs in broader populations are needed and should systematically include psychotherapy alongside antidepressants.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.